https://scholars.lib.ntu.edu.tw/handle/123456789/543747
標題: | The Role of Lymphovascular Invasion in Predicting the Prognosis of Clinically Localized Upper Tract Urothelial Carcinoma (pT1-3cN0M0) | 作者: | WEI-CHOU LIN Hu F.-C. Chung S.-D. SHIH-CHIEH CHUEH YEONG-SHIAU PU KUO-HOW HUANG |
公開日期: | 2008 | 卷: | 180 | 期: | 3 | 起(迄)頁: | 879-885 | 來源出版物: | Journal of Urology | 摘要: | Purpose: We assessed the impact of lymphovascular invasion on the prognosis of patients treated for clinically localized (pT1-3N0M0) upper tract urothelial carcinoma. Materials and Methods: From January 1998 to December 2004, 106 patients treated surgically for clinically localized upper tract urothelial carcinoma (pT1-3cN0M0) were recruited for analysis retrospectively. We assessed the impact of multiple prognostic factors including age, sex, smoking, tumor multiplicity, pathological stage, grading, squamous differentiation, subsequent bladder tumor recurrence, tumor site and lymphovascular invasion on the recurrence-free survival rate. We clarified the role of lymphovascular invasion in predicting cancer specific survival in these patients. Results: Mean patient age was 67.2 ± 11.1 years and median followup was 47.5 months (range 40 to 115). Lymphovascular invasion was present in 32 of 106 (30.2%) patients. The 5-year recurrence-free survival rate in patients with and without lymphovascular invasion was 65.3% and 91.9%, respectively (p <0.001). On multivariate analysis lymphovascular invasion status, pT3 and ureteral involvement were significant predictors of patient recurrence-free survival. The positivity of lymphovascular invasion was also significantly associated with the risk of higher stage disease (OR 7.49). Conclusions: Patients with lymphovascular invasion had a higher risk of greater pathological stage disease. Lymphovascular invasion and high stage disease with ureteral involvement led to a greater risk of disease recurrence and, in turn, recurrence caused a higher mortality rate. This finding could help identify patients at greater risk for disease recurrence who would benefit from close followup and early adjuvant therapy. ? 2008 American Urological Association. |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-48849084871&doi=10.1016%2fj.juro.2008.05.022&partnerID=40&md5=c79597e6dfac9b1094aa88ebf2e21bff https://scholars.lib.ntu.edu.tw/handle/123456789/543747 |
ISSN: | 0022-5347 | DOI: | 10.1016/j.juro.2008.05.022 | SDG/關鍵字: | adult; age distribution; aged; article; bladder tumor; cancer grading; cancer localization; cancer staging; cancer survival; cell differentiation; cigarette smoking; controlled study; female; follow up; human; lymph vessel; major clinical study; male; metastasis; priority journal; prognosis; sex difference; tumor recurrence; urinary tract carcinoma; Aged; Carcinoma, Transitional Cell; Chi-Square Distribution; Female; Follow-Up Studies; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Nephrectomy; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Retrospective Studies; Risk Assessment; Risk Factors; Survival Rate; Treatment Outcome; Urologic Neoplasms |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。